Filing Flows

Filing Flows › Pediatrix Medical Group (MD) › Q1 2026

Pediatrix Medical Group (MD) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 5, 2026

Pediatrix Medical Group (MD) reported revenue of $476M for the first quarter 2026 (Q1 2026), +4% from a year earlier and -4% from the quarter before. Operating margin was 8.7%, net earnings $29.6M (6.2% of revenue).

Revenue$476M
Year over year+4%
Quarter over quarter-4%
Operating margin8.7%
Net earnings$29.6M

Pediatrix Medical Group, Q1 2026: revenue $476M (+4% year over year), operating margin 8.7%, net earnings $29.6M, operating cash flow −$130M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$476M-4%+4%
Operating profit$41.7M-15%+30%
Net earnings$29.6M-12%+43%
Operating cash flow−$130M-214%—

What changed

Revenue was $476.2M in Q1 2026, up 4% year over year and down 4% from the previous quarter. Health Care Patient Service was the largest line at 85% of revenue. Health Care Patient Service added $16.0M year over year (up 4%), 90% of the total change. Product and Service Other declined 76%.

Operating profit was $41.7M, a 8.7% margin (up 1.7 points year over year). Of the extra revenue versus Q1 2025, 54% reached operating profit, above the 7% margin then. Total costs grew 2% against revenue growth of 4%. Net earnings were $29.6M, up 43% year over year. The effective tax rate was 23.9%.

Operating cash flow was −$129.8M. Non-cash charges added back $6.1M of depreciation and amortization and $4.7M of share-based compensation. Working capital and other items used $170.2M. Capital expenditures of $6.2M exceeded it, leaving free cash flow of −$136.1M.

Questions

What was Pediatrix Medical Group's revenue in the first quarter 2026?

Pediatrix Medical Group (MD) reported revenue of $476M for the first quarter 2026 (Q1 2026), +4% from a year earlier and -4% from the quarter before.

Was Pediatrix Medical Group profitable in the first quarter 2026?

Operating profit was $41.7M (8.7% of revenue) and net earnings $29.6M.

Open the interactive Sankey →

Source: Pediatrix Medical Group 10-Q on SEC EDGAR.